日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Exposure-Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

多尼达洛森治疗遗传性血管性水肿的暴露-反应分析

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70388
Singh, Pratap; Witjes, Han; Kleijn, Huub Jan; Diep, John K; Bordone, Laura; Newman, Kenneth B; Gao, Xiang; Cohn, Danny M
发表日期：2025
文献求助 收藏

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

终末期肾病透析患者克拉扎珠单抗的群体药代动力学和药代动力学-药效学分析

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70381
Muthukrishnan, Venkateswari Y; Kerbusch, Thomas; Strong, Laura E; Kleijn, Huub Jan; Pfister, Marc; Chang, Anna Marie; Acharya, Milin; Nandy, Partha; McCune, Jeannine S
发表日期：2025
文献求助 收藏

Population pharmacokinetic analysis of sparsentan in healthy volunteers and patients with focal segmental glomerulosclerosis

在健康志愿者和局灶节段性肾小球硬化症患者中对斯帕森坦进行群体药代动力学分析

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12996
Wada, Russell; Kleijn, Huub Jan; Zhang, Lu; Chen, Shang-Chiung
发表日期：2023
文献求助 收藏

Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling

贝祖替凡的群体药代动力学分析，为剂量考量和标签说明提供依据

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13028
Marathe, Dhananjay D; Jauslin, Petra M; Kleijn, Huub Jan; de Miranda Silva, Carolina; Chain, Anne; Bateman, Thomas; Shaw, Peter M; Abraham, Anson K; Kauh, Eunkyung A; Liu, Yanfang; Perini, Rodolfo F; de Alwis, Dinesh P; Jain, Lokesh
发表日期：2023
文献求助 收藏

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis

依库珠单抗在全身型重症肌无力患者中的药代动力学和药效学

期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2021.696385
Monteleone, Jonathan P R; Gao, Xiang; Kleijn, Huub Jan; Bellanti, Francesco; Pelto, Ryan
重症肌无力
免疫/内分泌
发表日期：2021
文献求助 收藏

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder

依库珠单抗在视神经脊髓炎谱系障碍患者中的药代动力学和药效学

期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2021.696387
Singh, Pratap; Gao, Xiang; Kleijn, Huub Jan; Bellanti, Francesco; Pelto, Ryan
神经科学
发表日期：2021
文献求助 收藏

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

两项针对难治性或不明原因慢性咳嗽的P2X3受体拮抗剂gefapixant的3期随机对照试验（COUGH-1和COUGH-2）的设计和原理

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00284-2020
Muccino, David R; Morice, Alyn H; Birring, Surinder S; Dicpinigaitis, Peter V; Pavord, Ian D; Assaid, Christopher; Kleijn, Huub Jan; Hussain, Azher; La Rosa, Carmen; McGarvey, Lorcan; Smith, Jaclyn A
信号转导
发表日期：2020
文献求助 收藏

Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile Infection

贝洛妥珠单抗在原发性和复发性艰难梭菌感染成人患者中的群体药代动力学和药效学研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01971-18
Yee, Ka Lai; Kleijn, Huub Jan; Kerbusch, Thomas; Matthews, Randolph P; Dorr, Mary Beth; Garey, Kevin W; Wrishko, Rebecca E
炎症/感染
发表日期：2019
文献求助 收藏